Photo from wikipedia
Onabotulinumtoxin A (BTX‐A) is an effective therapy for overactive bladder (OAB), however, adverse events may prevent patients from initiating therapy. The study objective was to report real‐world rates of incomplete… Click to show full abstract
Onabotulinumtoxin A (BTX‐A) is an effective therapy for overactive bladder (OAB), however, adverse events may prevent patients from initiating therapy. The study objective was to report real‐world rates of incomplete emptying and urinary tract infection (UTI) in men and women undergoing BTX‐A for OAB.
Keywords:
urinary tract;
bladder;
incomplete bladder;
emptying urinary;
overactive bladder
Journal Title: Neurourology and Urodynamics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Neurourology and Urodynamics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!